Vizgen has filed a notice of an exempt offering of securities to raise $50 Million in New Funding.
According to filings with the U.S. Securities and Exchange Commission, Vizgen is raising up to $50,000,000.00 in new funding. The federal securities law requires the notice to be filed by companies that have sold securities without registration under the Securities Act of 1933 in an offering made under Rule 504 or 506 of Regulation D or Section 4(a)(5) of the Securities Act. A company must file this notice within 15 days after the first sale of securities in the offering. For this purpose, the date of first sale is the date on which the first investor is irrevocably contractually committed to invest. Each issuer of securities that sells its securities in reliance on an exemption provided in Regulation D or Section 4(a)(5) of the Securities Act of 1933 must file this notice containing the information requested with the U.S. Securities and Exchange Commission (SEC) and with the state(s) requiring it. If more than one issuer has sold its securities in the same transaction, all issuers should be identified in this filing with the SEC.
About Vizgen
Vizgen is a leading company in innovative spatial biology technology, providing integrated spatial multiomics platforms that allow scientists to delve into the intricate details of cells with unmatched clarity. The company’s portfolio includes MERFISH 2.0 single-cell genomics on the MERSCOPE Platform, InSituPlex multiplex protein assays, and STARVUE AI analysis, which are utilized to map RNA and protein in tissue to reveal cell states, interactions, and disease mechanisms. With over 200 MERSCOPE Platforms installed globally and more than 400 MERFISH peer-reviewed and pre-print publications, Vizgen holds a significant market position in spatial biology solutions. Their technology is applied across various fields such as neuroscience, oncology, and immunology, empowering researchers to uncover deeper insights into disease and accelerate breakthroughs in human health.
To learn more about Vizgen, visit https://vizgen.com/
Vizgen Linkedin Page: https://www.linkedin.com/company/vizgen/
Contact:
Robert Carson, President and Chief Executive Officer
833-222-8206
https://www.linkedin.com/in/robcarson/
SOURCE: http://www.intelligence360.io
Copyright (c) 2026 SI360 Inc. All rights reserved.